Self-Supervised Movement Therapy for Stroke Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to learn how a partially self-supervised constraint-induced movement therapy (sCIMT) program in adults with arm and hand weakness will work after stroke. This study will look at whether the program can help people improve the use of their arm and hand after a stroke while requiring less time with a therapist. The main questions it aims to answer are:
* Does the sCIMT program help people use their affected arm and hand better - after a stroke?
* Do participants feel that the sCIMT program is useful, easy to follow, and a good fit for their recovery needs?
* Does taking part in the sCIMT program improve participants' quality of life and daily well-being?
Participants will:
* Take part in a therapy program 5x/week for 2 weeks. The program is designed to help improve the use of the arm and hand affected by stroke.
* Wear a mitt on the stronger hand during certain practice activities to encourage use of the weaker hand.
* Complete surveys and tests before and after the program to measure arm and hand use, experiences with the program, and quality of life.
Are You a Good Fit for This Trial?
This trial is for adults aged 18–85 who had their first stroke at least two weeks ago and have moderate weakness in one arm or hand. Participants must be able to follow simple instructions, have enough movement in the unaffected arm, and not have other major health issues affecting participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants take part in a self-supervised constraint-induced movement therapy (sCIMT) program 5 times a week for 2 weeks, designed to improve the use of the arm and hand affected by stroke.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of upper extremity function and quality of life.
What Are the Treatments Tested in This Trial?
Interventions
- Self-Supervised Constraint-Induced Movement Therapy (sCIMT)
Trial Overview
The study tests a self-supervised constraint-induced movement therapy (sCIMT) program where participants wear a mitt on their stronger hand to encourage use of the weaker one after stroke. The program runs five times per week for two weeks with less therapist supervision than usual.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will receive self-supervised constraint-induced movement therapy (sCIMT) to improve upper extremity function following stroke. The intervention consists of up to 30 hours of rehabilitation delivered over 2 weeks (3-hour sessions, up to 5 sessions per week). During each session, participants alternate between brief periods of one-to-one therapist-guided training and self-supervised task practice, with approximately one-third of treatment time provided individually by a therapist and two-thirds completed independently. Treatment activities include task-oriented functional and non-functional upper extremity exercises designed to promote motor recovery and use of the affected arm.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.